Search

Louise Wang Zhiying Humphrey

Examiner (ID: 17515)

Most Active Art Unit
1648
Art Unit(s)
1657, 1648
Total Applications
628
Issued Applications
269
Pending Applications
52
Abandoned Applications
313

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9625999 [patent_doc_number] => 08795674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Methods and compositions for modulating immune tolerance' [patent_app_type] => utility [patent_app_number] => 11/992880 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 60 [patent_no_of_words] => 20814 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11992880 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/992880
Methods and compositions for modulating immune tolerance Sep 27, 2006 Issued
Array ( [id] => 5316444 [patent_doc_number] => 20090281042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'COMPOSITIONS AND METHODS USING SAME FOR THE DETECTION OF VIRUSES' [patent_app_type] => utility [patent_app_number] => 12/066312 [patent_app_country] => US [patent_app_date] => 2006-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 30718 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281042.pdf [firstpage_image] =>[orig_patent_app_number] => 12066312 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/066312
COMPOSITIONS AND METHODS USING SAME FOR THE DETECTION OF VIRUSES Sep 9, 2006 Abandoned
Array ( [id] => 4704140 [patent_doc_number] => 20080063664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'High-yield transgenic mammalian expression system for generating virus-like particles' [patent_app_type] => utility [patent_app_number] => 11/515843 [patent_app_country] => US [patent_app_date] => 2006-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7751 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20080063664.pdf [firstpage_image] =>[orig_patent_app_number] => 11515843 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/515843
High-yield transgenic mammalian expression system for generating virus-like particles Sep 4, 2006 Abandoned
Array ( [id] => 5052090 [patent_doc_number] => 20070032635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes' [patent_app_type] => utility [patent_app_number] => 11/504974 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 27435 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032635.pdf [firstpage_image] =>[orig_patent_app_number] => 11504974 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/504974
Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes Aug 14, 2006 Abandoned
Array ( [id] => 5520847 [patent_doc_number] => 20090028828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Rotavirus Vaccine Inducing Heterotypic Cross Protection' [patent_app_type] => utility [patent_app_number] => 12/063602 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20707 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028828.pdf [firstpage_image] =>[orig_patent_app_number] => 12063602 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/063602
Rotavirus Vaccine Inducing Heterotypic Cross Protection Aug 14, 2006 Abandoned
Array ( [id] => 6577369 [patent_doc_number] => 20100047276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Recombinant Vectors Based On the Modified Vaccinia Ankara Virus (MVA) as Preventive and Therapeutic Vaccines Against Aids' [patent_app_type] => utility [patent_app_number] => 11/989425 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 41994 [patent_no_of_claims] => 120 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047276.pdf [firstpage_image] =>[orig_patent_app_number] => 11989425 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/989425
Recombinant vectors based on the modified vaccinia ankara virus (MVA) as preventive and therapeutic vaccines against AIDS Jul 24, 2006 Issued
Array ( [id] => 5733474 [patent_doc_number] => 20060258591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Compositions and methods of treating HIV infections' [patent_app_type] => utility [patent_app_number] => 11/491623 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19483 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258591.pdf [firstpage_image] =>[orig_patent_app_number] => 11491623 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/491623
Compositions and methods of treating HIV infections Jul 23, 2006 Abandoned
Array ( [id] => 263470 [patent_doc_number] => 07569228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Fusion proteins of non-attenuated HIV regulatory/accessory proteins' [patent_app_type] => utility [patent_app_number] => 11/488803 [patent_app_country] => US [patent_app_date] => 2006-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7644 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569228.pdf [firstpage_image] =>[orig_patent_app_number] => 11488803 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/488803
Fusion proteins of non-attenuated HIV regulatory/accessory proteins Jul 17, 2006 Issued
Array ( [id] => 6436668 [patent_doc_number] => 20100152601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'ASPIRATION STATE MONITORING DEVICE, ASPIRATION STATE MONITORING SYSTEM, BASE DEVICE, CONTROL SYSTEM, AND CONTROL SYSTEM USE METHOD' [patent_app_type] => utility [patent_app_number] => 11/993473 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9018 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152601.pdf [firstpage_image] =>[orig_patent_app_number] => 11993473 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/993473
ASPIRATION STATE MONITORING DEVICE, ASPIRATION STATE MONITORING SYSTEM, BASE DEVICE, CONTROL SYSTEM, AND CONTROL SYSTEM USE METHOD Jun 19, 2006 Abandoned
Array ( [id] => 4873225 [patent_doc_number] => 20080199959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Method For Cell Culture' [patent_app_type] => utility [patent_app_number] => 11/917169 [patent_app_country] => US [patent_app_date] => 2006-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2229 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199959.pdf [firstpage_image] =>[orig_patent_app_number] => 11917169 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/917169
Method For Cell Culture Jun 18, 2006 Abandoned
Array ( [id] => 8846048 [patent_doc_number] => 08455227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Detection of HIV-1 infection' [patent_app_type] => utility [patent_app_number] => 11/922404 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8729 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11922404 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/922404
Detection of HIV-1 infection Jun 14, 2006 Issued
Array ( [id] => 7977075 [patent_doc_number] => 08071284 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs' [patent_app_type] => utility [patent_app_number] => 11/916632 [patent_app_country] => US [patent_app_date] => 2006-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22179 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071284.pdf [firstpage_image] =>[orig_patent_app_number] => 11916632 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/916632
Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs Jun 5, 2006 Issued
Array ( [id] => 5699627 [patent_doc_number] => 20060216311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA' [patent_app_type] => utility [patent_app_number] => 11/441860 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12448 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216311.pdf [firstpage_image] =>[orig_patent_app_number] => 11441860 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/441860
Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA May 25, 2006 Abandoned
Array ( [id] => 5337858 [patent_doc_number] => 20090054322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Polypeptides and compositions comprising same and methods of using same for treating cxcr4 associated medical conditions' [patent_app_type] => utility [patent_app_number] => 11/920052 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18363 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054322.pdf [firstpage_image] =>[orig_patent_app_number] => 11920052 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/920052
Polypeptides and compositions comprising same and methods of using same for treating cxcr4 associated medical conditions May 24, 2006 Abandoned
Array ( [id] => 4758899 [patent_doc_number] => 20080311125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Scytovirin Domain 1 Related Polypeptides' [patent_app_type] => utility [patent_app_number] => 11/914833 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13612 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311125.pdf [firstpage_image] =>[orig_patent_app_number] => 11914833 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/914833
Scytovirin domain 1 related polypeptides May 23, 2006 Issued
Array ( [id] => 5582297 [patent_doc_number] => 20090101499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Protein-Immobilized membrane, method for immobilization of protein, enzyme-immobilized electrode, and biosensor' [patent_app_type] => utility [patent_app_number] => 11/920782 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5700 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20090101499.pdf [firstpage_image] =>[orig_patent_app_number] => 11920782 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/920782
Protein-Immobilized membrane, method for immobilization of protein, enzyme-immobilized electrode, and biosensor May 17, 2006 Abandoned
Array ( [id] => 303299 [patent_doc_number] => 07534435 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-19 [patent_title] => 'Glycosylated specificity exchangers' [patent_app_type] => utility [patent_app_number] => 11/411294 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20304 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/534/07534435.pdf [firstpage_image] =>[orig_patent_app_number] => 11411294 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/411294
Glycosylated specificity exchangers Apr 25, 2006 Issued
Array ( [id] => 5205020 [patent_doc_number] => 20070026502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Specificity exchangers that redirect antibodies to a pathogen' [patent_app_type] => utility [patent_app_number] => 11/412181 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21686 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026502.pdf [firstpage_image] =>[orig_patent_app_number] => 11412181 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/412181
Specificity exchangers that redirect antibodies to a pathogen Apr 25, 2006 Abandoned
Array ( [id] => 5890407 [patent_doc_number] => 20060276621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Glycosylated specificity exchangers' [patent_app_type] => utility [patent_app_number] => 11/411454 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18466 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276621.pdf [firstpage_image] =>[orig_patent_app_number] => 11411454 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/411454
Glycosylated specificity exchangers Apr 25, 2006 Issued
Array ( [id] => 8549047 [patent_doc_number] => 08323928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease' [patent_app_type] => utility [patent_app_number] => 11/277456 [patent_app_country] => US [patent_app_date] => 2006-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 7585 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11277456 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/277456
Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease Mar 23, 2006 Issued
Menu